Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer

Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer

US Patent 10401365 · Granted Sep 3, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and pharmaceutical compositions for the treatment of post-operative cogn2024
Methods and pharmaceutical compositions for the treatment of post-operative cogn2022
Microdevice for the in vivo capture of circulating cellular biomarkers2022
Method and pharmaceutical composition for use in the treatment of diabetes2019
Pharmaceutical composition for use in the treatment of dysfunction associated wi2016
Use of prebiotics, preferably glucooligosaccharide, for the prevention of the on2009
Colorants comprising cationic azacyanine dyes2008
Use of cationic azacyanine dyes for coloring keratin fibers2008
Cationic azacyanine dyes and coloring agents containing said dyes2008
Systemic delivery of compounds through non-invasive bladder administration2004